Jenin, Occupied West Bank(QNN)- Palestinian neurologist Thabat Marwan Al Khatib (27 years old) has become the first neurological researcher to patent the development of brand new pharmaceutical combinations that affect the neurons and improve their performance.
Al Khatib told WAFA that the combinations, which she developed, would be useful to treat various neurological diseases, especially Alzheimer’s disease.
“I began to discover these combinations by noting that the elderly and people with Alzheimer’s disease are experiencing a shortage in a chemical called “retinoic acid” and dysfunction in its work and production in the body,” Al Khatib told WAFA.
“I was able to develop similar, more powerful and more effective pharmaceutical combinations similar to retinoic acid. These combinations are still under examination in the laboratory to see how long their effects are,” she added.
The preliminary results obtained from the laboratory-cultured neurons are excellent and promising, according to Al Khatib.
Al Khatib has a Masters degree in Life Sciences and PhD degree in applied neuroscience with distinction from the University of Aberdeen, UK, and she works as a researcher in a post-doctoral fellowship program in the Department of Applied Neuroscience at the Faculty of Medicine, University of Aberdeen, UK.